Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Devasenapathy, Niveditha (23033698100)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial
    (2023)
    Karthikeyan, Ganesan (57188672173)
    ;
    Peix, Amalia (55899478200)
    ;
    Devasenapathy, Niveditha (23033698100)
    ;
    Jimenez-Heffernan, Amelia (55897520300)
    ;
    Haque, Saif-ul (57218168830)
    ;
    Rodella, Carlo (31067520000)
    ;
    Giubbini, Raffaele (7004319496)
    ;
    Rosas, Erick Alexanderson (57205709570)
    ;
    Ozkan, Elgin (7007024961)
    ;
    Keng, Yung Jih Felix (57942745400)
    ;
    Vitola, João (6602072314)
    ;
    Sobic-Saranovic, Dragana (57202567582)
    ;
    Soni, Manoj (57942104600)
    ;
    López, Leonardo (57941442200)
    ;
    Cabrera, Lázaro O. (14061659500)
    ;
    Camacho-Freire, Santiago (55515266200)
    ;
    Manovel-Sanchez, Ana (14520375700)
    ;
    Naeem, Hesham (57224600165)
    ;
    Fatima, Shazia (8331748200)
    ;
    Rinaldi, Roberto (57217700985)
    ;
    Carvajal-Juarez, Isabel (57203129644)
    ;
    Esenboga, Kerim (55965196800)
    ;
    Dondi, Maurizio (56789705600)
    ;
    Paez, Diana (54785022800)
    Background: In patients with multi-vessel disease presenting with ST elevation myocardial infarction (STEMI), the efficacy and safety of ischemia-guided, vs routine non-culprit vessel angioplasty has not been adequately studied. Methods: We conducted an international, randomized, non-inferiority trial comparing ischemia-guided non-culprit vessel angioplasty to routine non-culprit vessel angioplasty, following primary PCI for STEMI. The primary outcome was the between-group difference in percent ischemic myocardium at follow-up stress MPI. All MPI images were processed and analyzed at a central core lab, blinded to treatment allocation. Results: In all, 109 patients were enrolled from nine countries. In the ischemia-guided arm, 25/48 (47%) patients underwent non-culprit vessel PCI following stress MPI. In the routine non-culprit PCI arm, 43/56 (77%) patients underwent angioplasty (86% within 6 weeks of randomization). The median percentage of ischemic myocardium on follow-up imaging (mean 16.5 months) was low, and identical (2.9%) in both arms (difference 0.13%, 95%CI − 1.3%–1.6%, P <.0001; non-inferiority margin 5%). Conclusion: A strategy of ischemia-guided non-culprit PCI resulted in low ischemia burden, and was non-inferior to a strategy of routine non-culprit vessel PCI in reducing ischemia burden. Selective non-culprit PCI following STEMI offers the potential for cost-savings, and may be particularly relevant to low-resource settings. (CTRI/2018/08/015384). © 2022, The Author(s).

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback